Mirae Asset Global Etfs Holdings Ltd. Vera Therapeutics, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 25,735 shares of VERA stock, worth $1.25 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25,735Holding current value
$1.25 Million% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding VERA
# of Institutions
183Shares Held
54.9MCall Options Held
42.2KPut Options Held
114K-
Avoro Capital Advisors LLC New York, NY4.31MShares$210 Million2.13% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.62MShares$176 Million0.02% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$162 Million0.0% of portfolio
-
Abingworth LLP London, X02.96MShares$144 Million19.0% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA2.79MShares$136 Million5.61% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $1.32B
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...